RE:RE:Oncolytics Biotech® to Host Conference Call to Discuss Allow me to brief you on a few things that have transpired in 2020 with ONC: AWARE-1 interim results were presented by the President of SOLTI who was very pleased with and excited about them; BRACELET-1 dosed it's first patient; a whole new trial was announced with a new big pharma partner - IRENE trial. Does this provide you with some proof that ONC is doing something? Or does nothing else matter until you get a return on your investment - precluding that this IS a clinical stage biotech company??